Literature DB >> 15275715

Radiotherapy of squamous cell carcinoma of the nasal vestibule.

Johannes A Langendijk1, Robert Poorter, Christiaan R Leemans, Remco de Bree, Patricia Doornaert, Berend J Slotman.   

Abstract

PURPOSE: To evaluate the results of primary radiotherapy (RT) for squamous cell carcinoma of the nasal vestibule. METHODS AND MATERIALS: A total of 56 patients with Stage T1 and T2 tumors (Wang classification) were treated with external beam RT (EBRT) with or without a boost using endocavitary brachytherapy. Of these, 32 were treated with EBRT and an additional boost with intermediate-dose-rate brachytherapy, 15 with EBRT and a boost with high-dose-rate brachytherapy, and 9 with EBRT alone.
RESULTS: The local control rate at 2 years was 80%. Most cases could be successfully salvaged with surgery, resulting in an ultimate local control rate of 95%. No statistically significant differences were noted among the different treatment approaches. Of the 56 patients, 12% developed lymph node metastases.
CONCLUSION: Primary RT is an adequate treatment for Stage T1 and T2 squamous cell carcinoma of the nasal vestibule with excellent cosmetic results. The radiation technique used depends on the primary tumor extension and the experience of the treating radiation oncologist. In the case of N0 disease, elective treatment of the regional lymph nodes is not recommended.

Entities:  

Mesh:

Year:  2004        PMID: 15275715     DOI: 10.1016/j.ijrobp.2004.01.007

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Radiation therapy for nasal vestibule squamous cell carcinoma: a 40-year experience.

Authors:  Justin Wray; Christopher G Morris; Jessica M Kirwan; Robert J Amdur; John W Werning; Peter T Dziegielewski; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-13       Impact factor: 2.503

2.  Local control and intermediate-term cosmetic outcome following IMRT for nasal tumors : An update.

Authors:  Yuki Mukai; Stefan Janssen; Christoph Glanzmann; David Holzmann; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2016-12-05       Impact factor: 3.621

3.  Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: single-institution experience.

Authors:  Luca Tagliaferri; Nadia Carra; Valentina Lancellotta; Davide Rizzo; Calogero Casà; Giancarlo Mattiucci; Claudio Parrilla; Bruno Fionda; Francesco Deodato; Patrizia Cornacchione; Maria Antonietta Gambacorta; Gaetano Paludetti; Vincenzo Valentini; Francesco Bussu
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

4.  Squamous cell carcinoma of the nasal columella: a retrospective study of 66 cases from the GETTEC.

Authors:  Olivier Choussy; Emmanuel Babin; Stéphane Temam; Alain Cosmidis; Pierre-Olivier Vedrine; Dominique De Raucourt; Jérôme Sarini; Jean-Pierre Bessede; Pierre-Yves Lienhardt; Danièle Dehesdin
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-26       Impact factor: 2.503

5.  Endonasal resection of early stage squamous cell carcinoma of the nasal vestibule.

Authors:  Georg J Ledderose; Simone Reu; Anna S Englhard; Eike Krause
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-22       Impact factor: 2.503

6.  Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy.

Authors:  Fabian Eberle; Rita Engenhart-Cabillic; Markus M Schymalla; Christoph Dumke; Ulrike Schötz; Florentine S B Subtil; Kilian-Simon Baumann; Boris A Stuck; Christine Langer; Alexandra D Jensen; Henrik Hauswald; Stefan Lautenschläger
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.